Some reasons of insufficient efficiency of anti-influenza vaccination.
Fridman
E
E
Pasteur Institute of Epidemiology and Microbiology, Leningrad, USSR.
Bichurina
M
M
Rozaeva
N
N
Brjanceva
E
E
Poljanskaja
N
N
D000818:Animals; D000940:Antigenic Variation / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007114:Immunization; D009980:Influenza A virus / Q000276:immunology / Q000302:isolation & purification; D007252:Influenza Vaccines / Q000276:immunology*; D051379:Mice; D015164:Vaccines, Inactivated / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology
D000956:Antigens, Viral; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic